rs104895300

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3PP5_Moderate

The NM_000431.4(MVK):​c.500C>A​(p.Pro167Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P167L) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 33)

Consequence

MVK
NM_000431.4 missense

Scores

6
9
4

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 3.43
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr12-109581523-C-T is described in Lovd as [Pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.766
PP5
Variant 12-109581523-C-A is Pathogenic according to our data. Variant chr12-109581523-C-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2098514.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MVKNM_000431.4 linkc.500C>A p.Pro167Gln missense_variant Exon 5 of 11 ENST00000228510.8 NP_000422.1 Q03426B2RDU6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MVKENST00000228510.8 linkc.500C>A p.Pro167Gln missense_variant Exon 5 of 11 1 NM_000431.4 ENSP00000228510.3 Q03426

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria Pathogenic:1
May 10, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant disrupts the p.Pro167 amino acid residue in MVK. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10369262, 11313769). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MVK protein function. This variant has not been reported in the literature in individuals affected with MVK-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 167 of the MVK protein (p.Pro167Gln). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.62
.;D;D;D
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.80
T;T;.;T
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.77
D;D;D;D
MetaSVM
Pathogenic
0.82
D
MutationAssessor
Uncertain
2.4
.;.;M;M
PrimateAI
Benign
0.36
T
PROVEAN
Pathogenic
-4.8
D;D;D;.
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0040
D;T;T;.
Sift4G
Uncertain
0.011
D;T;T;T
Polyphen
0.95
.;.;P;P
Vest4
0.55, 0.55
MutPred
0.62
Loss of stability (P = 0.0945);Loss of stability (P = 0.0945);Loss of stability (P = 0.0945);Loss of stability (P = 0.0945);
MVP
0.98
MPC
0.90
ClinPred
0.97
D
GERP RS
4.2
Varity_R
0.33
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-110019328; API